Geri
NervGen Pharma Corp (NGENF) Fiyatı
NGENF Hisse Senedi Fiyat Grafiği
NGENF Kazanmak
NervGen Pharma Corp
$5.63
2.92%
$0.16
Kapanışta: Jan 16, 16:00:00 GMT-5
$5.63
0%
$0
Sonrası Piyasa: Jan 16, 20:00:00 GMT-5
Önemli İstatistikler
Önceki Kapanış
$5.47
Açılış fiyatı
$5.3
Günün Aralığı
$5.3 - $5.81
52 haftalık aralık
$1.5 - $6.3
İşlem hacmi
27.4K
Ort.Hacim
143.6K
EPS (TTM)
-0.26
Dividend yield
--
Piyasa Değeri
$445.9M
NGENF nedir?
NervGen Pharma Corp. operates as a clinical stage biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-03-13. The firm is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved